Key stats
About VanEck Pharmaceutical ETF
Expense ratio
0.36%
Home page
Inception date
Dec 20, 2011
PPH provides exposure to the largest, US-listed multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, capping a single issuer to 20%. Still, it captures the space well, even after excluding Asia entirely. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies. The index is reviewed on a semi-annual basis.
Classification
What's in the fund
Exposure type
Health Technology
Distribution Services
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.